Blair R Leavitt1, Sarah J Tabrizi2. 1. Centre for Molecular Medicine and Therapeutics, and Centre for Huntington's Disease at UBC Hospital, Department of Medical Genetics and Division of Neurology, Department of Medicine, University of British Columbia and BC Children's Hospital, Vancouver, Canada. s.tabrizi@ucl.ac.uk bleavitt@cmmt.ubc.ca. 2. Huntington's Disease Centre, Department of Neurodegenerative Disease, and UK Dementia Research Institute at UCL, UCL Queen Square Institute of Neurology, University College London, London, UK. s.tabrizi@ucl.ac.uk bleavitt@cmmt.ubc.ca.
Authors: Roy Maimon; Carlos Chillon-Marinas; Cedric E Snethlage; Sarthak M Singhal; Melissa McAlonis-Downes; Karen Ling; Frank Rigo; C Frank Bennett; Sandrine Da Cruz; Thomas S Hnasko; Alysson R Muotri; Don W Cleveland Journal: Nat Neurosci Date: 2021-06-03 Impact factor: 24.884
Authors: Peter H Hagedorn; Jeffrey M Brown; Amy Easton; Maria Pierdomenico; Kelli Jones; Richard E Olson; Stephen E Mercer; Dong Li; James Loy; Anja M Høg; Marianne L Jensen; Martin Gill; Angela M Cacace Journal: Nucleic Acid Ther Date: 2022-02-14 Impact factor: 4.244
Authors: Cristina Salado-Manzano; Unai Perpiña; Marco Straccia; Francisco J Molina-Ruiz; Emanuele Cozzi; Anne E Rosser; Josep M Canals Journal: Front Cell Neurosci Date: 2020-08-11 Impact factor: 6.147